Page 162 - ESHRE2019

Call for wider testing Kramer, Donor Sibling Registry (DSR), Bionews 2009
• DSR campaigning for ‘comprehensive medical testing of gamete donors’ – Karyotyping
– Wide range of ARD, since offspring with those conditions have been born to non‐high risk group donors.
– Fragile X (any potential donor within the premutation range should be excluded).
– Mutations known to cause breast and ovarian cancers, haemochromatosis, melanoma, coeliac
disease, polyposis and non‐polyposis colorectal cancers and polycystic kidney disease.
– The objective in donor screening should be orientated towards full genome testing as soon as such a possibility becomes economically feasible and our understanding of genetic mutations makes such an endeavour worthwhile.
https://www.bionews.org.uk/page_91988
“Instead of giving in to the illusion of ‘preventative perfectionism’, the message of the profession should be that avoiding all risks is impossible and that testing should remain proportional”
160
156